Plus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PSTV and other ETFs, options, and stocks.About PSTV
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs.
CEOMarc H. Hedrick
CEOMarc H. Hedrick
Employees21
Employees21
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded1996
Founded1996
Employees21
Employees21
PSTV Key Statistics
Market cap50.60M
Market cap50.60M
Price-Earnings ratio-0.15
Price-Earnings ratio-0.15
Dividend yield—
Dividend yield—
Average volume25.20M
Average volume25.20M
High today$0.3787
High today$0.3787
Low today$0.2625
Low today$0.2625
Open price$0.31
Open price$0.31
Volume57.89M
Volume57.89M
52 Week high$2.31
52 Week high$2.31
52 Week low$0.1634
52 Week low$0.1634
Stock Snapshot
The current Plus Therapeutics(PSTV) stock price is $0.28, with a market capitalization of 50.6M. The stock trades at a price-to-earnings (P/E) ratio of -0.15.
On 2026-01-23, Plus Therapeutics(PSTV) stock traded between a low of $0.26 and a high of $0.38. Shares are currently priced at $0.28, which is +7.4% above the low and -25.5% below the high.
Plus Therapeutics(PSTV) shares are trading with a volume of 57.89M, against a daily average of 25.2M.
In the last year, Plus Therapeutics(PSTV) shares hit a 52-week high of $2.31 and a 52-week low of $0.16.
In the last year, Plus Therapeutics(PSTV) shares hit a 52-week high of $2.31 and a 52-week low of $0.16.
People also own
Based on the portfolios of people who own PSTV. This list is generated using Robinhood data, and it’s not a recommendation.